Richard Kenney
Direttore Tecnico/Scientifico/R&S presso SONNET BIOTHERAPEUTICS HOLDINGS, INC.
Patrimonio netto: 1 298 $ in data 31/05/2024
Posizioni attive di Richard Kenney
Società | Posizione | Inizio | Fine |
---|---|---|---|
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2021 | - |
American Federation for Medical Research | Corporate Officer/Principal | - | - |
American Society of Tropical Medicine & Hygiene
American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services The American Society of Tropical Medicine & Hygiene is a health community dedicated to reducing the worldwide burden of tropical infectious diseases and improving health. The non-profit company is based in Northbrook, IL. Members have access to research on the latest diseases and treatments, a standing within their community, learning about clinical cases and field work, and finding collaborators. | Corporate Officer/Principal | - | - |
ClinReg Biologics LLC | Presidente | 01/09/2016 | - |
Storia della carriera di Richard Kenney
Precedenti posizioni note di Richard Kenney
Società | Posizione | Inizio | Fine |
---|---|---|---|
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/07/2017 | 01/02/2021 |
IMMUNE DESIGN CORP | Direttore Tecnico/Scientifico/R&S | 19/09/2013 | 16/06/2016 |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Direttore Tecnico/Scientifico/R&S | 01/07/2012 | 01/08/2013 |
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 19/01/2010 | - |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2009 | 01/01/2009 |
░░░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
░░ ░░░░ ░ ░░░░ ░░░░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Richard Kenney
George Washington University | Undergraduate Degree |
Harvard Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Canada | 2 |
Paesi Bassi | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Settori
Health Technology | 9 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MARKER THERAPEUTICS, INC. | Health Technology |
SONNET BIOTHERAPEUTICS HOLDINGS, INC. | Health Technology |
Aziende private | 10 |
---|---|
Vical, Inc.
Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |
Intercell USA, Inc.
Intercell USA, Inc. BiotechnologyHealth Technology Intercell USA, Inc. discovers and develops vaccines and immune system stimulants. The vaccine patch enhances the efficacy of existing vaccines, enables new vaccines that are viable only through transcutaneous administration and expand the global vaccine market. The company was founded by Gregory M. Glenn and Dean P. Lewis in September 1997 and is headquartered in Gaithersburg, MD. | Health Technology |
American Federation for Medical Research | |
American Society of Tropical Medicine & Hygiene
American Society of Tropical Medicine & Hygiene Miscellaneous Commercial ServicesCommercial Services The American Society of Tropical Medicine & Hygiene is a health community dedicated to reducing the worldwide burden of tropical infectious diseases and improving health. The non-profit company is based in Northbrook, IL. Members have access to research on the latest diseases and treatments, a standing within their community, learning about clinical cases and field work, and finding collaborators. | Commercial Services |
Immune Design Corp.
Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
Janssen Vaccines & Prevention BV
Janssen Vaccines & Prevention BV Pharmaceuticals: MajorHealth Technology Janssen Vaccines & Prevention BV manufactures and supplies biopharmaceutical products. The company was founded in 2000 and is headquartered in Leiden, the Netherlands. | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
ClinReg Biologics LLC | |
X-Vax Technology, Inc.
X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Richard Kenney
- Esperienza